CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT03582618 · TERMINATED
Trial details
- NCT number
- NCT03582618
- Sponsor
- TaiRx, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2021-11-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.